Inflammatory mediators from monocytes down-regulate cellular proliferation and enhance cytokines production in patients with polar clinical forms of Chagas disease

Human Immunology

Volumn 75, Issue 1, 2014, Pages 20-28

  Gomes, Juliana Assis Silva ^a,b   Molica, Andreia Maria ^a,b   Keesen, Tatjana Souza Lima ^c   Morato, Maria José Ferreira ^b   de Araujo, Fernanda Fortes ^b   Fares, Rafaelle Christine Gomes ^b   Fiuza, Jacqueline Araujo ^b   Chaves, Ana Thereza ^b   Pinheiro, Vladimir ^a,b   Nunes, Maria do Carmo Pereira ^a   Correa Oliveira, Rodrigo ^b,d   da Costa Rocha, Manoel Otávio ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^b INSTITUTO OSWALDO CRUZ   (Brazil)

^c FEDERAL UNIVERSITY OF PARAÍBA   (Brazil)

^d National Institute of Science and Technology for Tropical Diseases   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

B7 ANTIGEN; CYTOKINE; GAMMA INTERFERON; HLA DR ANTIGEN; INDOMETACIN; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; PARASITE ANTIGEN; PROSTAGLANDIN E2; TUMOR NECROSIS FACTOR ALPHA;

ADHERENT CELL; ADULT; AGED; ARTICLE; B LYMPHOCYTE; CELL PROLIFERATION; CHAGAS DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOWN REGULATION; HUMAN; HUMAN CELL; IMMUNOSTIMULATION; MONOCYTE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRYPANOSOMA CRUZI;

CARD; CD; CLUSTER OF DIFFERENTIATION; HLA-DR; IL; IND; INTERLEUKIN; MHC CLASS II CELL SURFACE RECEPTOR; NI; NON-INFECTED INDIVIDUALS; PATIENTS WITH INDETERMINATE CLINICAL FORM OF CHAGAS DISEASE; PATIENTS WITH THE CARDIAC CLINICAL FORM OF CHAGAS DISEASE; PGE2; PROSTAGLADIN E2; TRYPO; TRYPOSMASTIGOTES ANTIGEN;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIGENS, PROTOZOAN; B-LYMPHOCYTES; CELL PROLIFERATION; CELLS, CULTURED; CHAGAS CARDIOMYOPATHY; CHAGAS DISEASE; CYTOKINES; DINOPROSTONE; GENE EXPRESSION; HLA-DR ANTIGENS; HUMANS; INDOMETHACIN; INFLAMMATION MEDIATORS; LEUKOCYTES, MONONUCLEAR; MONOCYTES; TRYPANOSOMA CRUZI;

EID: 84890172006     PISSN: 01988859     EISSN: 18791166     Source Type: Journal    
DOI: 10.1016/j.humimm.2013.09.009     Document Type: Article

References (29)

1. De Barros-Mazon S., Guariento M.E., da Silva C.A., Coffman R.L., Abrahamsohn I.A. Differential regulation of lymphoproliferative responses to Trypanosoma cruzi antigen in patients with the cardiac or indeterminate form of Chagas disease. Clin Immunol 2004, 111:137-145.
2. Rocha M.O., Teixeira M.M., Ribeiro A.L. An update on the management of Chagas cardiomyopathy. Expert Rev Anti Infect Ther 2007, 5:727-743.
3. Petkova S.B., Tanowitz H.B., Magazine H.I., Factor S.M., Chan J., Pestell R.G., et al. Myocardial expression of endothelin-1 in murine Trypanosoma cruzi infection. Cardiovasc Pathol 2000, 9:257-265.
4. Mukherjee S., Machado F.S., Huang H., Oz H.S., Jelicks L.A., Prado C.M., et al. Aspirin treatment of mice infected with Trypanosoma cruzi and implications for the pathogenesis of Chagas disease 12. PLoS One 2011, 6:E16959.
5. Harris S.G., Padilla J., Koumas L., Ray D., Phipps R.P. Prostaglandins as modulators of immunity. Trends Immunol 2002, 23:144-150.
6. Sreeramkumar V., Fresno M., Cuesta N. Prostaglandin E(2) And T Cells: friends or foes? 1. Immunol Cell Biol 2012, 90:579-586.
7. Celentano A.M., Gorelik G., Solana M.E., Sterin-Borda L., Borda E., Gonzalez Cappa S.M. PGE2 involvement in experimental infection with Trypanosoma cruzi subpopulations 8. Prostaglandins 1995, 49:141-153.
8. Cardoni R.L., Antunez M.I. Circulating levels of cyclooxygenase metabolites in experimental Trypanosoma cruzi infections. Mediators Inflamm 2004, 13:235-240.
9. Harizi H., Gualde N. Pivotal role of PGE2 And IL-10 in the cross-regulation of dendritic cell-derived inflammatory mediators. Cell Mol Immunol 2006, 3:271-277.
10. Gomes J.A., Bahia-Oliveira L.M., Rocha M.O., Martins-Filho O.A., Gazzinelli G., Correa-Oliveira R. Evidence that development of severe cardiomyopathy in human Chagas' disease is due to a Th1-specific immune response 4. Infect Immun 2003, 71:1185-1193.
11. De Araujo F.F., Correa-Oliveira R., Rocha M.O., Chaves A.T., Fiuza J.A., Fares R.C., et al. Foxp3(+) Cd25(High) Cd4(+) regulatory T cells from indeterminate patients with Chagas disease can suppress the effector cells and cytokines and reveal altered correlations with disease severity 1. Immunobiology 2012, 217:768-777.
12. Keesen T.S., Gomes J.A., Fares R.C., Araujo F.F., Ferreira K.S., Chaves A.T., et al. Characterization Of Cd4(+) cytotoxic lymphocytes and apoptosis markers induced by Trypanossoma cruzi infection 2. Scand J Immunol 2012, 311-319.
13. Rocha M.O., Teixeira M.M., Ribeiro A.L. An update on the management of Chagas cardiomyopathy 4. Expert Rev Anti Infect Ther 2007, 5:727-743.
14. Gazzinelli G., Katz N., Rocha R.S., Colley D.G. Immune responses during human Schistosomiasis mansoni. X. Production and standardization of an antigen-induced mitogenic activity by peripheral blood mononuclear cells from treated, but not active cases of Schistosomiasis. J Immunol 1983, 130:2891-2895.
15. Chen R., Lowe L., Wilson J.D., Crowther E., Tzeggai K., Bishop J.E., Varro R. simultaneous quantification of six human cytokines in a single sample using microparticle-based flow cytometric technology. Clin Chem 1999, 45:1693-1694.
16. Kuroda E., Yamashita U. Mechanisms of enhanced macrophage-mediated prostaglandin e2 production and its suppressive role in th1 activation in Th2-dominant Balb/C mice. J Immunol 2003, 170:757-764.
17. Dutra W.O., Gollob K.J. Current concepts in immunoregulation and pathology of human Chagas disease. Curr Opin Infect Dis 2008, 21:287-292.
18. Costa G.C., da Costa Rocha M.O., Moreira P.R., Menezes C.A., Silva M.R., Gollob K.J., et al. Functional IL-10 gene polymorphism is associated with Chagas disease cardiomyopathy 20. J Infect Dis 2009, 199:451-454.
19. Mizoguchi A., Bhan A.K. A case for regulatory B cells 9. J Immunol 2006, 176:705-710.
20. Abdalla G.K., Faria G.E., Silva K.T., Castro E.C., Reis M.A., Michelin M.A. Trypanosoma cruzi: the role of PGE2 in immune response during the acute phase of experimental infection. Exp Parasitol 2008, 118:514-521.
21. Machado F.S., Mukherjee S., Weiss L.M., Tanowitz H.B., Ashton Anthony W. Bioactive lipids in Trypanosoma cruzi infection. Adv Parasitol 2011, 76:1-31.
22. Tanowitz H.B., Mukhopadhyay A., Ashton A.W., Lisanti M.P., Machado F.S., Weiss L.M., et al. Microarray analysis of the mammalian thromboxane receptor-Trypanosoma cruzi interaction. Cell Cycle 2011, 10(7):1132-1143.
23. Cetron M.S., Basilio F.P., Moraes A.P., Sousa A.Q., Paes J.N., Kahn S.J., et al. Humoral and cellular immune response of adults from Northeastern Brazil with chronic Trypanosoma cruzi infection: depressed cellular immune response to T. Cruzi antigen among chagas' disease patients with symptomatic versus indeterminate infection. Am J Trop Med Hyg 1993, 49:370-382.
24. De Barros-Mazon S., Guariento M.E., Abrahamsohn I.A. IL-12 enhances proliferation of peripheral blood mononuclear cells from Chagas' disease patients to Trypanosoma cruzi antigen 1. Immunol Lett 1997, 57:39-45.
25. Cunha-Neto E., Kalil J. Heart-infiltrating and peripheral T cells in the pathogenesis of human Chagas' disease cardiomyopathy. Autoimmunity 2001, 34:187-192.
26. Yao C., Sakata D., Esaki Y., Li Y., Matsuoka T., Kuroiwa K., et al. Prostaglandin E2-Ep4 signaling promotes immune inflammation through Th1 Cell differentiation and Th17 cell expansion 4. Nat Med 2009, 15:633-640.
27. Sakai T., Inoue S., Ta Matsuyama., Takei M., Ota H., Katagiri T., et al. Eosinophils may be involved in thrombus growth in Acute Coronary Syndrome. Int Heart J 2009, 50(3):267-277.
28. Stenina M.A., krivov L.I., Voevodin D.A., Savchuk V.I., Kovalchuk L.V., Yarygin V.N. Cytokine profile of the blood in mice with normal and abnormal heart rhythm1. Bull Exp Biol Med 2012, 152:692-695.
29. Piedras J., Gutierrez S., Reyes-Lopez P.A., Reyes K., Lopez-Karpovitch X., Monteon V. Circulating lymphocyte subpopulations and activated T And B cells in patients with Chagasic and Non-Chagasic myocardiopathy 2. Cytometry 1997, 30:28-32.